Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 12010
TargetMacrophage colony-stimulating factor 1 receptor(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 0.420nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
Affinity DataIC50: 0.930nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 1.80nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetMacrophage colony-stimulating factor 1 receptor(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 2.20nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 7.5nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetMacrophage colony-stimulating factor 1 receptor(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 10nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 15nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 30nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
Affinity DataIC50: 85nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 289nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
TargetMacrophage colony-stimulating factor 1 receptor(Human)
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Goharmony Therapeutics (Shenzhen) Co.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The operation method is briefly described as follows:The powders of the compound were dissolved in 100% DMSO to make a 10 mM stock solution. The init...More data for this Ligand-Target Pair
